Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Pediatric Nephrology (Berlin, Germany)|May 2, 2013
Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology ConsortiumCaroline Straatmann, Rose Ayoob, Rasheed Gbadegesin, et al.Clinical Kidney Journal|June 6, 2025
Elevated exposure to air pollutants accelerates primary glomerular disease progressionJonathan P Troost, Abhijit V Kshirsagar, Lawrence S Engel, et al.Pediatrics|August 5, 2009
Management of childhood onset nephrotic syndromeDebbie S Gipson, Susan F Massengill, Lynne Yao, et al.Kidney International Reports|June 7, 2023
Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" ApproachSagar Bhayana, Yue Zhao, Michael Merchant, et al.Plos One|February 2, 2013
Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritisAdam J Guess, Rose Ayoob, Melinda Chanley, et al.Kidney International Reports|January 11, 2020
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma ProteomicsShipra Agrawal, Michael L Merchant, Jiro Kino, et al.BMC Nephrology|February 24, 2026
Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular diseaseYu Kamigaki, Julie A Dougherty, Amanda P Waller, et al.Pediatric Nephrology (Berlin, Germany)|June 5, 2025
Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022Michelle R Denburg, Kathryn Hirabayashi, Amy Goodwin Davies, et al.Environmental Health : a Global Access Science Source|June 5, 2026
Air pollution and disease progression among patients with primary glomerular disease: an expanded study with extended follow-upJonathan P Troost, Abhijit V Kshirsagar, William E Smoyer, et al.Pediatric Nephrology (Berlin, Germany)|August 13, 2009
Management patterns of childhood-onset nephrotic syndromeNathaniel MacHardy, Paul V Miles, Susan F Massengill, et al.Pageof 13